BioNTech, a German maker of the COVID-19 vaccine, predicts that existing technology can be used. A new vaccine was produced to tackle the new strain of COVID in 6 weeks.
BioNTech CEO Ugur Sahin said he thinks the company can use the existing COVID-19 vaccine, developed with Pfizer, to produce a vaccine that will still be effective against COVID-19. New species. He said it was the beauty of mRNA technology that could produce new vaccines.
Scientists will be able to understand the emerging new vaccine by separating England from the rest of the country. As many countries have tried to suspend travel Avoid traveling to and from England. Or suspend the transportation of goods More than 40 countries have now banned travel.
After the British found a new strain of COVID in late September. The virus has spread so rapidly that five countries now have new strains of COVID, including Denmark, Iceland, the Netherlands, Australia and Italy, although the British authorities warned that the new strain of COVID is easier to infect, Dr Ugur is confident. That the vaccine produced today can resist And if a new vaccine has to be produced, it can be done in 6 weeks.
However, Dr Sahin argues that scientists are not optimistic. But I think that things are similar, they can work relatively high. Although the new virus will have some changes. But there are many parts of the virus that haven’t changed much. This includes the immunity associated with the vaccination. The fight against infections such as T Cell (a specific immune He said it would have to assure them that the T-cells were responsive. Which has to be tested in large enough quantities To see if it still works or not
Dr Sahin said it could take at least two weeks for lab trials. To prove that the vaccine from BioNTech / Pfizer The approved will work well in England. United States and the European Union?
In addition, Ozlem Tureci, head of bioNTech medicine, said the mRNA technology used to develop the vaccine should make it easier to develop vaccines for new strains of COVID. Which vaccines from BioNTech / Pfizer It has been approved by the European Medicines Agency (European Medicines Agency) after many countries began to adopt, such as the United Kingdom, the United States.
Joe Biden said that the new leader of the United States was just getting vaccinated from Pfizer / BioNTech took the first dose. He received the first dose of vaccine after being vaccinated to healthcare workers one day after the US Food and Drug Administration approved the emergency vaccine.
Today, I received the COVID-19 vaccine.
To the scientists and researchers who worked tirelessly to make this possible — thank you. We owe you an awful lot.
And to the American people — know there is nothing to worry about. When the vaccine is available, I urge you to take it. pic.twitter.com/QBtB620i2V
— Joe Biden (@JoeBiden) December 22, 2020
The company is likely to begin distributing the drug to the European Union by December 26. The vaccine will first begin shipping to the UK, the US, Canada and Israel. BioNTech will deliver 45 million doses of the vaccine by the end of the year. That includes 12.5 million doses of the EU, 20 million doses of the vaccine.The company aims to produce around 1.3 billion doses of the vaccine by the end of 2021.
Origin – Financial Times, CNN, NPR
Follow the news from Brand Inside from our Facebook.
Related
– .
